BioCrine
  • Home
  • About Us
    • Company and People
    • Board of Directors
    • Management
    • Partners
  • Research Programs
    • Pipeline overview
    • Diabetes as a disease
    • Biocrine drug discovery strategy
    • Serum factor apoCIII
    • Insulin receptor isoforms
    • Calcium channels
    • Inositol pyrophosphates
  • InSight Technology
    • What is it?
    • How does it work?
    • Where can it be used?
  • News
  • Contact
Home » News » Publication » Beta cell plasticity

Beta cell plasticity

InSight Technology has been used to show the pancreatic islets of Langerhans adapt their content of insulin-producing beta-cells to changing insulin need. The results are published in PNAS in November 2013. 

Blood glucose levels vary in an individual from one meal to the next as well as between meals. Variation can also seen between individuals. The body compensates for this variation by producing different amounts of insulin that regulates blood sugar levels.

In conditions, such as obesity, when more insulin is needed, the pancreatic islets of Langerhans try to adapt themselves to high blood sugar levels by generating more insulin-producing beta-cells. The exact process has been hard to study due to the fact that the islets of Langerhans sit deeply embedded in the surrounding pancreatic tissue.

Researchers in Professor P-O Berggren’s group have been able to overcome this challenge by employing InSight Technology. The islets of Langerhans were placed into the anterior chamber of the mouse eye. Using pharmacological treatment, the mice under evaluation reduced their food intake. This resulted in reduced growth of beta-cell population in the islet of Langerhans.

The results are published in PNAS in November 2013.

Read more:

  1. Reporter islets in the eye reveal plasticity of the endocrine pancreas. Erwin Ilegems, Andrea Dicker, Stephan Speier, Aarti Sharma, Alan Bahow, Patrick Karlsson Edlund, Ingo B. Leibiger, Per-Olof Berggren. Proceedings of the National Academy of Sciece (PNAS) U S A. 2013 Nov 18
  2. Press release from Karolinska Institutet
November 21, 2013 Catharina Rahm

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Categories

Recent posts

  • Professor Berggren’s research publications
    Professor Berggren’s research publications February 6, 2025
  • Årsstämma 17 juni 2024
    Årsstämma 17 juni 2024 June 2, 2024
  • Researchers use the eye as a window to study liver health
    Researchers use the eye as a window to study liver health February 8, 2024
  • ERC Proof of Concept to Professor Per-Olof Berggren
    ERC Proof of Concept to Professor Per-Olof Berggren February 7, 2024
  • The anterior chamber of the eye as a servant to medical research in translation
    The anterior chamber of the eye as a servant to medical research in translation February 7, 2024
  • Lisa Juntti-Berggren receives the Swedish Society of Medicine’s Jubilee Prize
    Lisa Juntti-Berggren receives the Swedish Society of Medicine’s Jubilee Prize February 7, 2024
  • Eye implant may be used to treat diabetes
    Eye implant may be used to treat diabetes February 7, 2024
  • Årsstämma 16 juni 2023
    Årsstämma 16 juni 2023 May 29, 2023
  • New strategy to preserve insulin-producing cells in diabetes
    New strategy to preserve insulin-producing cells in diabetes August 19, 2022
  • Kallelse till årsstämma 27 juni 2022
    Kallelse till årsstämma 27 juni 2022 June 6, 2022

Biocrine AB

Box 3073

169 03 Solna, Sweden

Contact Us

info at biocrine.se

www.biocrine.com

Copyright © 2012 Biocrine AB. All Rights Reserved